Literature DB >> 8094415

Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients.

W K Dahlberg1, J B Little, J A Fletcher, H D Suit, P Okunieff.   

Abstract

Skin fibroblast cell strains and tumour cell lines were established from 12 patients with various types of soft tissue neoplasms, and radiation survival curve parameters were measured in vitro. Soft tissue sarcoma cells were consistently more sensitive to X-irradiation than fibroblasts isolated from the same patient, and were also more sensitive as a group than cell lines derived from 34 other human tumours. There was a general correlation in radiosensitivity between fibroblasts and tumour cells derived from the same patient, indicating that some component of tumour cell sensitivity may relate to genetic factors in the host. Such genetic factors, however, do not explain all of the heterogeneity in tumour cell response. The response of soft tissue sarcoma in vivo may be dependent on complex radiomodifying factors other than inherent radiation sensitivity, thus making it difficult to predict clinical outcome by use of assays which use survival of irradiated tumour cell lines in vitro as an endpoint.

Entities:  

Mesh:

Year:  1993        PMID: 8094415     DOI: 10.1080/09553009314550251

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  27 in total

1.  Relevance of MPNST cell lines as models for NF1 associated-tumors.

Authors:  Eric Pasmant; Armelle Luscan; Jennifer Varin; Ingrid Laurendeau; Béatrice Parfait; Dominique Vidaud
Journal:  J Neurooncol       Date:  2013-06-27       Impact factor: 4.130

Review 2.  [Genetic predisposition and radiation sensitivity of tumors].

Authors:  W Budach
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

3.  Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner.

Authors:  Thomas J Turbyville; Demirkan B Gürsel; Robert G Tuskan; Jessica C Walrath; Claudia A Lipschultz; Stephen J Lockett; David F Wiemer; John A Beutler; Karlyne M Reilly
Journal:  Mol Cancer Ther       Date:  2010-05-04       Impact factor: 6.261

4.  Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

Authors:  J E DeClue; S Heffelfinger; G Benvenuto; B Ling; S Li; W Rui; W C Vass; D Viskochil; N Ratner
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.

Authors:  Matthew Wood; Melissa Rawe; Gunnar Johansson; Shu Pang; Ryan S Soderquist; Ami V Patel; Sandra Nelson; William Seibel; Nancy Ratner; Yolanda Sanchez
Journal:  Mol Cancer Ther       Date:  2011-06-22       Impact factor: 6.261

6.  Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.

Authors:  Adrienne L Watson; Eric P Rahrmann; Branden S Moriarity; Kwangmin Choi; Caitlin B Conboy; Andrew D Greeley; Amanda L Halfond; Leah K Anderson; Brian R Wahl; Vincent W Keng; Anthony E Rizzardi; Colleen L Forster; Margaret H Collins; Aaron L Sarver; Margaret R Wallace; Stephen C Schmechel; Nancy Ratner; David A Largaespada
Journal:  Cancer Discov       Date:  2013-03-27       Impact factor: 39.397

7.  Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.

Authors:  Jenell M Eckert; Stephanie J Byer; Buffie J Clodfelder-Miller; Steven L Carroll
Journal:  Glia       Date:  2009-11-01       Impact factor: 7.452

8.  A novel isoform of beta-spectrin II localizes to cerebellar Purkinje-cell bodies and interacts with neurofibromatosis type 2 gene product schwannomin.

Authors:  Y Chen; P Yu; D Lu; D A Tagle; T Cai
Journal:  J Mol Neurosci       Date:  2001-08       Impact factor: 2.866

9.  Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents.

Authors:  Amy N Turk; Stephanie J Byer; Kurt R Zinn; Steven L Carroll
Journal:  J Vis Exp       Date:  2011-03-07       Impact factor: 1.355

10.  Impaired Pten expression in human malignant peripheral nerve sheath tumours.

Authors:  Maren Bradtmöller; Christian Hartmann; Jan Zietsch; Sebastian Jäschke; Victor-F Mautner; Andreas Kurtz; Su-Jin Park; Michael Baier; Anja Harder; David Reuss; Andreas von Deimling; Frank L Heppner; Nikola Holtkamp
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.